Research programme: anti-inflammatory peptides - Riptide Bioscience
Latest Information Update: 28 Sep 2020
Price :
$50 *
At a glance
- Originator Riptide Bioscience
- Class Peptides
- Mechanism of Action Cytokine modulators; Inflammation mediator modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for preclinical development in Inflammation in USA (SC)
- 28 Sep 2020 No recent reports of development identified for preclinical development in Inflammation in USA (Topical)
- 07 Aug 2016 Preclinical trials in Inflammation in USA (SC)